In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Previews, April 2015

Executive Summary

This Month's Profile Group, Prostate Cancer Diagnostics, features profiles of 3DBiopsy, Blue Earth Diagnostics, Prostate Management Diagnostics, and UroSens. Plus these Start-Ups Across Health Care: Global Blood Therapeutics, MenoGenix, and Velano Vascular.

You may also be interested in...



Velano Vascular Inc.

Velano Vascular Inc. aims to spare hospitalized patients the pain of numerous needle blood draws. It is commercializing a single-use, disposable vascular-access device that resembles a syringe and interacts with an existing peripheral intravenous catheter that has already been inserted in the patient’s hand or arm.

3DBiopsy LLC

3DBiopsy LLC thinks its technology could significantly improve a physician’s ability to diagnose and treat patients suspected of having prostate cancer. It has developed a complete biopsy system that utilizes the start-up’s proprietary software to transform ultrasound or MRI imaging into 3D models of the prostate and give physicians a more accurate guide.

Prostate Cancer: Dissatisfaction With Current Diagnostics Drives Interest In Innovation

The lack of accurate tools for diagnosing the severity of prostate cancer creates opportunities for start-ups with novel approaches. Profiles of 3D Biopsy, Blue Earth Diagnostics, UroSens, and Prostate Management Diagnostics.

Related Content

Topics

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel